ArticleJournal of neuro-oncology2018

Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model.

Toshitaka Fujihara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.